1,298 material Form 8-K filings that 1,057 companies we cover made with the SEC in April 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Ovintiv closed the sale of its Anadarko assets in Oklahoma on April 9, 2026, with the buyer paying $2.9 billion in cash after preliminary closing adjustments. The company said proceeds will go to debt reduction and that the sale achieves its debt target. Ovintiv also plans to repay C$1.57 billion under its Credit Agreement on April 10, 2026 and redeem $700 million of 5.650% notes due 2028 on April 20, 2026.
Buyer MidCon II BuyerCo, LLC paid $2.9 billion in cash after preliminary closing adjustments; the press release cites expected proceeds of about $2.85 billion after customary adjustments
Sold approximately 360,000 net acres in west-central Oklahoma, with an effective date of January 1, 2026
Credit Agreement borrowings of C$1.57 billion to be repaid April 10, 2026, after which the agreement terminates
$700 million aggregate principal of 5.650% notes due 2028 to be redeemed April 20, 2026
On April 9, 2026, Atlas Energy Solutions issued $450 million of 0.50% convertible senior notes due April 15, 2031, including the full exercise of a $60 million option. The company used part of the proceeds to repay Stonebriar advances and ABL borrowings and to fund about $50 million for capped call transactions meant to reduce dilution. The notes add debt, and conversion into common stock at about $14.51 per share could dilute existing shareholders.
$450 million of 0.50% convertible senior notes due April 15, 2031, including the $60 million option exercised in full
Initial conversion price of about $14.51 per share, a 30% premium over the $11.16 close on NYSE on April 6, 2026
Capped call transactions cost about $50 million, with a cap price of $22.32 per share
Press release says about $66 million will repay Stonebriar advances (including a $5 million termination fee) and about $75 million will repay ABL borrowings
On April 9, 2026, EOG updated its first quarter 2026 guidance for current tax expense, raising it to $500 million-$600 million from the $230 million-$330 million range it gave on February 24, 2026. EOG said higher crude oil prices in the first quarter, and those expected for the full year, tied to the Middle East conflict drove the change. EOG is not updating any other first quarter or full year 2026 guidance ranges from February.
Q1 2026 current tax expense guidance now $500 million-$600 million, up from $230 million-$330 million.
EOG cited higher crude oil prices realized in Q1 2026 and anticipated for full year 2026 due to the Middle East conflict.
NYMEX West Texas Intermediate crude averaged $72.17 per barrel and Henry Hub natural gas averaged $4.96 per million British thermal units in Q1 2026.
EOG paid net cash of $53 million to settle financial commodity derivative contracts in Q1 2026; no other guidance ranges were updated.
On April 7, 2026, Fifth Era Acquisition Corp I (FERA), a special purpose acquisition company, agreed to combine with SMT Holdings Limited, which operates as Miotal, a holder of high-purity strategic metals. Miotal's shares are to be exchanged for Holdco ordinary shares valued at $10 billion, and FERA's Class A and Class B shares are to convert one-for-one into Holdco shares. The filing does not include revenue, profit or earnings figures for Miotal, and closing depends on FERA shareholder approval, a registration statement and Nasdaq listing approval.
Business Combination Agreement dated April 7, 2026, with Miotal SPAC HoldCo, Inc., PENNY Merger Sub, Inc. and SMT Holdings Limited
Miotal shares to be exchanged for Holdco shares valued at $10 billion, with each Holdco share valued at $10.00
Miotal estimates its metals stockpile at about $35 billion at prevailing market prices, which it says may vary substantially
Closing expected in the first half of 2026; sponsor must cover or reduce shares if PENNY Transaction Costs exceed $15,000,000
Skydance (PSKY) signed a secured credit agreement on April 7, 2026 with banks to fund its pending acquisition of WBD, with the term loans and revolver drawn only at deal closing. The same day it expanded an existing revolver to $5.00 billion, and it cut the bridge financing commitments for the deal from $54.00 billion to $49.00 billion. President and board member Jeffrey Shell left the company effective April 8, 2026, with severance-type payments, and the filing states that the WBD closing remains subject to conditions and regulatory clearances.
Pro Rata Credit Agreement dated April 7, 2026: $2.50 billion three-year Term A-1 loans, $2.50 billion five-year Term A-2 loans and a $5.00 billion five-year revolving facility, available once the WBD acquisition closes.
Bridge commitments for the WBD financing reduced from $54.00 billion to $49.00 billion; $3.50 billion 365-day revolving commitments reduced to $0.00.
Amendment No. 7 raised the existing revolver by $1.50 billion to $5.00 billion, reducing to $4.94 billion in January 2027 with maturity in January 2028.
Jeffrey Shell separated effective April 8, 2026, receiving 12 months of base salary plus target bonus, accelerated RSU vesting and up to 12 months of company-subsidized health and dental coverage.
Valmont Industries appointed John Schwietz as Executive Vice President, Chief Financial Officer and Corporate Secretary, effective April 8, 2026, succeeding Thomas Liguori. Schwietz has worked at Valmont since 2009, most recently as President of International Agriculture since May 2024, so the change is a leadership transition in the finance function rather than a change in company operations.
John Schwietz named EVP, Chief Financial Officer and Corporate Secretary, effective April 8, 2026
He succeeds Thomas Liguori in the CFO role
Schwietz, age 44, joined Valmont in 2009 and has held finance, business development and operations roles
Since May 2024 he has served as President, International Agriculture
Simply Good Foods reported fiscal second-quarter 2026 net sales of $326.0 million, down from $359.7 million a year earlier, and a net loss of $159.7 million, driven by a $249.0 million non-cash impairment charge on the Atkins and OWYN brands. The company also updated its fiscal 2026 outlook, with net sales now expected at $1.31 to $1.35 billion and adjusted EBITDA at $217 to $225 million, and gave a third-quarter net sales range of $329 to $338 million.
Q2 net sales of $326.0 million fell 9.4%; Atkins declined 26.6% and OWYN 16.8%, while Quest grew 0.3%.
Q2 net loss of $159.7 million compared with net income of $36.7 million; adjusted diluted EPS was $0.45 versus $0.46.
Fiscal 2026 outlook: net sales $1.31 to $1.35 billion and adjusted EBITDA $217 to $225 million; gross margin expected to decline 300 to 350 basis points.
Q3 outlook: net sales of $329 to $338 million, down 14% to 11%, and adjusted EBITDA of $46 to $50 million.
Neogen reported fiscal third-quarter 2026 revenue of $211.2 million, down 4.4% from a year earlier, and a net loss of $17.0 million, or $(0.08) per share, compared with a $10.9 million loss a year earlier. The company raised its fiscal 2026 revenue guidance to $857 million to $860 million, kept Adjusted EBITDA guidance at about $175 million, and announced a $160.0 million sale of its Genomics business to Zoetis.
Q3 revenue was $211.2 million, down from $221.0 million; Animal Safety revenue fell 20.1% on third-party supplier issues
Net loss was $17.0 million, or $(0.08) per diluted share; Adjusted EPS was $0.09 versus $0.10 a year earlier
FY26 revenue guidance raised to $857 million to $860 million from $845 million to $855 million; Adjusted EBITDA guidance held at about $175 million
Genomics business to be sold to Zoetis Inc. for $160.0 million, expected to close by the end of fiscal 2Q27
Mountain Lake Acquisition Corp. II, a blank check company, and quantum technology firm Terra Quantum AG signed a non-binding letter of intent for a business combination that values Terra Quantum at $3.25 billion. The letter does not bind either party, and the filing states there is no assurance a definitive agreement will be signed or the deal completed.
Proposed deal values Terra Quantum AG at $3.25 billion, per the April 9, 2026 press release
Letter of intent is non-binding; completion depends on a definitive agreement and conditions not yet negotiated
Any transaction would require due diligence, board and shareholder approvals, and regulatory approvals
MLAC II's Class A Ordinary Shares trade on Nasdaq under the ticker MLAA
On April 9, 2026, Chevron gave preliminary first-quarter 2026 estimates that mix higher oil and gas prices with several negative items. Higher commodity prices are expected to add $1.6 billion to $2.2 billion to upstream earnings versus fourth quarter 2025, but timing effects and a litigation charge are expected to weigh on earnings and cash flow. Final results are due on or around May 1, 2026, and the figures are unaudited and could change.
Timing effects, after tax, are expected to reduce first-quarter earnings and cash flow from operations excluding working capital by about $2.7 billion to $3.7 billion, mostly in Downstream.
Upstream earnings are expected to benefit by $1.6 billion to $2.2 billion from higher commodity prices compared with fourth quarter 2025.
A Downstream litigation reserve tied to ceased operations is expected to bring a charge of about $350 million to $400 million after tax.
Upstream net production is expected at 3.8 to 3.9 million barrels of oil-equivalent per day, reflecting downtime at Tengizchevroil and reduced Middle East output.
Treace Medical preliminarily reported first-quarter 2026 revenue of $47.0 million to $47.2 million and cash of about $51.9 million, and raised the low end of its full-year 2026 revenue guidance to $202 million to $212 million. The company also said Chief Commercial Officer Gaetano M. Guglielmino departed effective April 8, 2026, and will not be replaced, with his duties moved to existing staff and the head of sales reporting to the CEO.
Preliminary Q1 2026 revenue: $47.0 million to $47.2 million (unaudited; subject to financial closing procedures)
Cash, equivalents and marketable securities about $51.9 million at March 31, 2026, up about $3.5 million from $48.4 million at December 31, 2025
2026 revenue guidance updated to $202 million to $212 million, from $200 million to $212 million previously
Chief Commercial Officer Gaetano M. Guglielmino departed April 8, 2026; consulting agreement runs through January 31, 2027 at a monthly fee of $36,666.67
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.